Journal of pharmaceutical policy and practice, 2020
Whaley, C., Bancsi, A., Ho, J., Burns, C. M., & Grindrod, K. (2020). How do I keep myself safe? Patient perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis. Journal of Pharmaceutical Policy and Practice.
Whaley, C., Ashley Bancsi, J. Ho, Catherine M. Burns, and K. Grindrod. “How Do I Keep Myself Safe? Patient Perspectives on Including Reason for Use Information on Prescriptions and Medication Labels: a Qualitative Thematic Analysis.” Journal of pharmaceutical policy and practice (2020).
Whaley, C., et al. “How Do I Keep Myself Safe? Patient Perspectives on Including Reason for Use Information on Prescriptions and Medication Labels: a Qualitative Thematic Analysis.” Journal of Pharmaceutical Policy and Practice, 2020.
Abstract Background Medications are crucial for maintaining patient wellness and improving health in modern medicine, but their use comes with risks. Helping patients to understand why they are taking medications is important for patient-centered care and facilitates patient adherence to prescribed medications. One strategy involves enhancing communication between patients, physicians, and pharmacists through the sharing of reason for use (RFU) information or the indication for medications. Methods Semi-structured interviews were conducted with 20 patients in Ontario, Canada, to gain perspectives on how patients currently store their medication information and benefits and disadvantages of adding RFU to prescriptions and medication labels. An interview guide was used by the two interviewers, and the interviews were recorded, transcribed, and thematically coded. Results The analysis yielded three main themes: patient decision making with RFU, RFU in modern, patient-centered care, and logistical aspects of communicating RFU. The patients that were interviewed expressed the value of having RFU when deciding if a medication was effective or to stop taking the medication. Patients felt comfortable with RFU being added to prescriptions and acknowledged the value in adding RFU to medication labels, helping patients and others identify and distinguish medications. Patients generally expressed interest in having RFU written in lay language and identified strengths and weaknesses of having access to RFU via a website or app. Conclusions Patients rated the importance of knowing RFU very highly, identified the value in sharing RFU with pharmacists on prescriptions, and in having RFU on medication labels. These results can be used to inform policy on the addition of RFU on prescriptions and medication labels and support improved communication between patients, pharmacists, and physicians about RFU.